DNA Script Investors

39 investors on Angel Roster list DNA Script in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in France, the Netherlands and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name DNA Script can appear together.

Investors listed
39
With verified email
33%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 39 DNA Script investors

The most complete profiles first. Showing 39 of 39.

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Bao DinhVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Christophe SimonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Eric GallerneVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Luc MaruendaVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Matthieu BaretVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas DebockVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas NedelecVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Robin RivatonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Annette Fainbloom

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Matthieu B.

    Venture Capital, Private Equity Firm, Investor · France

    SeedPre-SeedHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas de Loiray

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Daniel Emersleben

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Florian Zimmermann

    Private Equity Firm · Germany

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Jean Plamondon

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Julian Schubert

    Venture Capital, Corporate Venture Capital · Germany

    Health CareConsumer GoodsInfrastructureChemical

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Nicolas Chaudron

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Thierry Legeais

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Wallace Wallace

    Venture Capital, Corporate Venture Capital · Netherlands

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • George PetrocheilosVerified

    Venture Capital, Founder, Investor · United States

    SeedCybersecurityRoboticsBiotechnologyClinical Trials

    Portfolio: DNA Script, Spiral Therapeutics

    Verified email available

Frequently asked questions

How many DNA Script investors are on Angel Roster?

Angel Roster lists 39 DNA Script investors. 13 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (30), Venture Capital Firms (22) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do DNA Script investors invest in?

Among those that list a stage, the most common are Seed (14), Series B (5) and Pre-Seed (1).

Where are DNA Script investors based?

Most are based in France (20), the Netherlands (7) and Germany (5).

Which companies have DNA Script investors backed?

The most-backed portfolio companies among them are Vico Therapeutics (28), AM Pharma (28), Pharvaris (28), Minoryx Therapeutics (23) and Cardiologs (23).

How do I contact DNA Script investors?

Create a free Angel Roster account to search and filter all 39, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.